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Androgens have been linked to the onset, severity, and progression of rheumatoid arthritis (RA). In traditional Chinese medicine
(TCM), the most common pattern in RA is kidney deﬁciency, which partly corresponds to a low sex hormone state. In this study,
TCM kidney deﬁciency was induced in male Sprague-Dawley rats with castration surgery, and a TCM preparation, Yi Shen Juan
Bi Pill (YJB), was used to treat collagen induced arthritis (CIA) rats with castration. Metabolomic technique was used to evaluate
the pharmacological mechanism in castrated CIA rats treated by YJB. The results showed that castration signiﬁcantly increased
the severity of the arthritis in rats but was ameliorated by YJB. Its pharmacological mechanism was partially associated with lipid
metabolitesinvolvingfreefattyacid(FFA)andlysophosphatidylcholine(LPC).Inconclusion,theexperimentalresultsdemonstrate
the protective eﬀect of YJB on the TCM kidney deﬁciency pattern induced by androgen deﬁciency in CIA rats and support that
YJB should be used for the clinical treatment of RA with TCM kidney deﬁciency pattern.
1.Introduction
Rheumatoid arthritis (RA) is a systemic autoimmune disease
thatprimarilypresentsaschronicsymmetricpolyarthritisas-
sociated with inﬂammation and cartilage destruction. Epi-
demiological data suggest that approximately 1% of the
world’s population is aﬄicted with RA [1]. It is hypothesized
that hormonal factors play a pathogenic role in RA onset
[2–4].
In traditional Chinese medicine (TCM), RA is catego-
rized as Bi Zheng (Bi syndrome or blockage syndrome). The
TCM kidney deﬁciency pattern is the most common pattern
addressed to manage RA; thereby reinforcing the TCM
kidney is an important therapeutic target for RA [5, 6]. The
Chinese patent drug Yi Shen Juan Bi pill (YJB) was approved
(no. Z10890004) and has been marketed in pill form in
China since 1987. The formula was prepared by the National
TCM master professor Zhu Liangchun, and YJB has been
proven as an eﬀective treatment for RA with TCM kidney
deﬁciency pattern [7]. YJB has been shown to ameliorate
RA symptoms and to decrease the erythrocyte sedimentation
rate (ESR), as well as C-reactive protein (CRP) and rheuma-
toid factor (RF) levels [8]. Recent studies have elucidated
the mechanisms used by YJB; speciﬁcally, it signiﬁcantly
decreased prostaglandin E (PGE) and upregulated the pro-
apoptotic family member Bax in rat synovium and decreased
the production of peritoneal macrophage-derived tumor
necrosis factor-alpha, interleukin 1 and nitric oxide [9–11].
Interestingly, a clinical trial suggested that YJB combined
with methotrexate was eﬀective in treating elderly onset RA,
which was characterized by low plasma testosterone [12].
However, the pharmacological activity and mechanisms of
YJB in the treatment of RA with kidney deﬁciency pattern
are not clear.
TCM kidney deﬁciency was reported to be induced in
castrated rats [13]. It has also been hypothesized that low2 Evidence-Based Complementary and Alternative Medicine
levels of sex hormones partially correspond to TCM kidney
deﬁciency pattern [14]. Therefore, castrated rats are a
suitable animal model for TCM kidney deﬁciency [13, 15].
The formulation of the YJB consists of complex com-
ponents; therefore, it is challenging to understand thera-
peutic mechanisms with conventional methods. Recently
metabolomic approaches have been utilized to understand
pharmacological mechanisms of related compound Chinese
herbs [16, 17]. In the present study, we established collagen-
induced arthritis (CIA) in rats to evaluate the eﬀect of YJB
treatment on inﬂammatory responses in normal CIA rats
andCIAratswithcastration-inducedTCMkidneydeﬁciency
pattern. We also obtained metabolic proﬁles of plasma from
CIA rats with TCM kidney deﬁciency with or without YJB
treatment to supply further evidence for the clinical appli-
cation of YJP in the treatment of RA with TCM kidney
deﬁciency.
2.MaterialsandMethods
2.1. Materials. YJB was obtained from GMP-approved
Jiangsu Zhengda Qingjiang Pharmaceutical Co., Ltd. HPLC-
gradeacetonitrileandformicacidwaspurchasedfromMerck
(USA). Freund’s incomplete adjuvant and bovine type II col-
lagen were purchased from Sigma-Aldrich (MO, USA). IL-
6 (BMS625) and IL-10 (BMS629) assay kits were purchased
from Bender (USA). Ultrapure water was from a Milli-Q50
SP Reagent Water System (Millipore Corporation, USA).
2.2. Animal Handling Procedure. Male Sprague-Dawley (SD)
rats (150 ± 10g) were purchased from the Institute of Exper-
imental Animals in the Chinese Academy of Medical Science
(rodent license no. SYXK 11-00-0039). The rats were housed
under standard laboratory conditions, and food and tap
water were provided ad libitum. Experimental procedures
were reviewed and approved by the Animal Care and Use
Committee in the China Academy of Chinese Medical
Sciences before the animal experiments were carried out.
Castration was performed according to standard surgical
procedures under pentobarbital anesthesia. In brief, a single
incision was made in the scrotal skin, and the testicles were
squeezed out with gentle pressure. The spermatic cord was
ligated with chromic catgut, and scrotal incisions were treat-
ed as open wounds.
Arthritis was induced as previously described, 4 weeks
after castration [18, 19]. Brieﬂy, rats were intradermally
injected at the base of tail with 100μg of bovine type II col-
lagen in 0.05M acetic acid emulsiﬁed with an equal amount
ofincompleteFreund’sadjuvant.Theratsweregivenaboost-
er with the same preparation 7 days after the primary im-
munization.
2.3. Experimental Groups and Drug Treatment. The experi-
mental groups (n = 10) were as follows: (1) normal control
(NC), (2) collagen-induced arthritis (CIA), (3) castration-
induced kidney deﬁciency arthritis, and (4) castrated CIA
rats with YJB treatment. On day 15 after the primary im-
munization, one group began receiving daily YJB (2.4g/kg
body weight) by intragastric administration for 14 days. The
dose was based on the clinical application dosage of 24g per
day per 60kg body weight. Other groups were treated with
an equal volume of distilled water as a vehicle control.
2.4. Arthritis Assessment. CIA rats were assessed for disease
severity every 2 days after the booster immunization. Arthri-
tis severity was expressed as mean arthritic index on a 0 to 4
scaleaccordingtotheconventionalmethod[20].Inaddition,
j o i n tt i s s u eh i s t o p a t h o l o g yw a sa s s e s s e dw i t hH&Es t a ining.
Inﬂammation, pannus, cartilage damage, and bone damage
were scored on scales from 0 to 3 (0: absent; 1: weak; 2:
moderate; 3: severe) [21].
2.5. Measurement of IL-6 and IL-10. Serum levels of IL-6
and IL-10 were measured with ELISA according to the
manufacturer’s instructions. Brieﬂy, blood serum was har-
vested after the rats were sacriﬁced and diluted 1:10. The
absorbance was read at 450nm using a microplate reader.
Samples and standards were analyzed in triplicate.
2.6. Anti-Col II Antibody Measurement. The serum level
of anti-Col II antibody was measured by ELISA. Brieﬂy,
collagenwasdissolvedtoaﬁnalconcentrationof10μg/mLin
acetic acid (0.1moL/L), and the resulting solution was
applied to 96-well ﬂat-bottomed microtiter plates at 4◦C
overnight. Next, the wells were incubated with 0.5% oval-
bumin at room temperature for 1h to reduce nonspeciﬁc
binding. After washing with phosphate-buﬀered saline con-
taining Tween, diluted test serum and standards were added
to the Col II-coated wells. Next, the biotin-conjugated goat
aﬃnity-puriﬁed antibody to rat IgG and sequentially
streptavidin-HRP were added. The reaction was terminated
by the addition of stop buﬀer, and absorbance was measured
at 450nm.
2.7. HPLC-Q-TOF-MS Conditions. HPLC-Q-TOF-MS anal-
ysis was performed on a Water-Q-TOF Micro MS system
coupled with an electrospray ionization (ESI) source (Water
Technologies, UK). Samples were separated on an Eclipse
plus C18 column with the column temperature set at 35◦C.
Data were collected in full scan mode from 100 to 1000m/z
from 0 to 30min. The standard sample ran six times con-
tinuously to conﬁrm the stability of the method. The mass
detection was operated in both positive and negative ion
modes (ﬂow rate: 8L/min, gas temperature: 250◦C, pressure
of nebulizer gas: 35psig, Vcap: 3kV, fragmentor: 160V,
skimmer: 65V). Target MS analysis was used to identify
potential biomarkers.
2.8. Metabolomic Data Analysis. The raw data were analyzed
with MarkerLynx software (Waters, UK) for peak decon-
volution and alignment. The parameters were as follows:
mass tolerance was set at 0.05Da, peak width was set at
≥1.5%, baseline noise elimination was set at level 4, and the
mass window was set at 0.1min. The data were combined
into a single matrix by aligning peaks with the same
mass/retention time (0.3–12min) from each data ﬁle in theEvidence-Based Complementary and Alternative Medicine 3
dataset, along with their associated normalized intensities.
Principal component analysis (PCA) was performed with
SIMCA-Psoftware(Version12.0,UMETRICSAB,Box 7960,
SE 90719, Umea, Sweden) to visualize general clustering for
further identiﬁcation of diﬀerentially expressed metabolites
that might account for the separation between YJB-treated
rats and other groups.
2.9. Statistical Analysis. All of the quantitative data analyses
were performed using SPSS 11.5 software package for Win-
dows. Signiﬁcance was determined with one-way analyses
of variance (ANOVAs) followed by Student’s t-tests. Results
were expressed mean ± SD. P values less than 0.05 were
considered signiﬁcant.
3. Results
3.1. Change on Sex Hormone and Arthritic Evaluation. Cas-
tration-induced TCM kidney deﬁciency can signiﬁcantly
reduce dihydrotestosterone, testosterone, and estradiol se-
rum levels in rats. No signiﬁcant diﬀerences in these hor-
mone levels were detected in the YJB-treated group com-
pared to castrated arthritic control group (Supplemen-
tary Data S1 available online at doi:10.1155/2012/102641).
Arthritis was reproducibly induced in both normal rats and
castration-induced kidney deﬁciency rats that were given
collagen combined with ICFA (data not show). The results
showed signiﬁcantly increased paw edema in castrated
arthritic rats, which was suppressed by YJB administration
(Figure 1). Histological evaluation of joint tissue demon-
strated that, compared with CIA rats, castrated CIA rats
showed extensive cartilage erosion, ﬁbroplasia, and synovial
membrane thickening (Figure 2(c)).Clinical evaluations and
histological studies demonstrated that the severity score was
higher in castrated CIA rats compared to normal CIA rats
(P<0.01, Figure 2(e)); YJB treatment reduced degradation
and resulted in a signiﬁcantly lower severity score compared
to castrated CIA rats (P<0.01, Figures 2(d) and 2(e)).
3.2. Serum Levels of Anti-Collagen Type II, IL-6, and IL-10.
Castrated CIA rats developed a signiﬁcantly higher immune
response in terms of antibody generation against type II
collagen compared to the CIA control (P<0.01). The
antibody titers of castrated CIA rats were signiﬁcantly atten-
uated by YJB administration (P<0.05, Figure 3). Arthritis
induction caused increased serum levels of IL-6. While
castrated CIA rats exhibited an on-going IL-6 increase (P<
0.05), this increase was signiﬁcantly suppressed by YJB
treatment (P<0.05, Figure 4). However, the opposite was
true for IL-10. Castrated CIA rats treated with YJB had sig-
niﬁcantly higher levels of IL-10 level compared to castrated
CIA rats (P<0.01, Figure 5).
3.3. Metabolite Identiﬁcation. In order to understand the
role of the castration-induced kidney deﬁciency in arthritis
onset, we performed serum metabolic proﬁling of normal
control rats, CIA control rats, and castrated arthritic rats.
Figure 6(a) shows a clear separation trend of metabolites
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Figure 1: Paw edema by treatment (n = 10/group). YJB treatment
suppresses paw swelling in castrated arthritic rats. Data are
expressed as means ± SD (∗∗P<0.01).
between normal rats, CIA rats, and castrated CIA rats using
unsupervised analysis of PCA. This result suggests that
castration-induced kidney deﬁciency perturbed the met-
abolic proﬁle of castrated arthritic rats.
To ascertain the eﬀect of YJB on serum metabolite
perturbation in castrated arthritic rats, we examined the
metabolic proﬁles of serum in normal rats, castrated CIA
rats, and castrated CIA rats treated with YJB. Figure 6(b)
shows a clear separation of scores between normal control
rats and castrated arthritic rats, and a clear separating trend
between castrated CIA rats and castrated CIA rats treated
with YJB. This ﬁnding suggests that YJB could ameliorate the
pathological state induced by arthritis and castration. These
results support the hypothesis that YJB has a therapeutic
eﬀect on arthritic rats with castration-induced TCM kidney
deﬁciency pattern.
Over 300 peaks were obtained using LC-TOF-MS ana-
lytical protocols coupled with a software-based peak decon-
volution procedure. Student’s t-tests were performed on
all metabolites. The variables selected were those with sta-
tistically signiﬁcant diﬀerences (P<0.05) between normal
control rats, castrated CIA rats, and YJB-treated rats. A total
of 20 individual metabolites were signiﬁcantly diﬀerent.
Compound identiﬁcation was performed with commer-
cially available authentication standards. Among these per-
turbed variables, 14 (7 upregulated and 7 downregu-
lated) were predicted by comparing the accurate MS and
MS-MS fragments with metabolites found in databases
(http://metlin.scripps.edu/; http://www.hmdb.ca/) that were
later conﬁrmed with commercial standards. Most of the
metabolites were lipids, such as LPC and FFA (Supplemen-
tary Data S2). The statistical results demonstrated that YJB
may downregulate LPC (Figure 7(a)) and upregulate FFA in
the serum of castrated CIA rats (Figure 7(b)).4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Histological evaluation of the joint tissue. Paraﬃn sections of knee joints were stained with H & E. Scale = 100μm. (a) Sham group
treated with distilled water; (b) CIA rats treated with distilled water; (c) castrated arthritic rats treated with distilled water; (d) castrated
arthritic rats treated with YJB; (e) pathological severity score. Pathological changes were scored on a 1 to 3 scale. Data are expressed as means
± SD (∗∗P<0.01).
4. Discussion
A major ﬁnding of this study is that CIA rats with castration-
induced TCM kidney deﬁciency can develop severe arthritis,
and YJB could have a therapeutic eﬀect in castrated CIA rats.
This result supports the clinical application of YJB in the
treatment of RA patients with TCM kidney deﬁciency
pattern.
It is well known that sex hormones, which are impor-
tant factors in TCM kidney deﬁciency [5–7], might have
a pathogenic role in RA onset. It has been reported that RA
occurs 3-4 times more frequently in women than in men [2].
Furthermore, men with RA have lower serum testosterone
levels than healthy men [3], and male gender has been found
to be a major predictor of remission in early RA [4]. In our
results, castrated male rats developed severe arthritis after
collagen immunization.
YJB is a TCM compound that is hypothesized to
reinforce kidney function. YJB consists of 20 medicinal
materials, including Fructus Xanthii, Herba Cistanchis, RadixEvidence-Based Complementary and Alternative Medicine 5
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Figure 3: Changes of anti-Col II IgG in serum (n = 10). The level
of anti-Col II was measured by ELISA. Data are expressed as means
± SD (∗∗P<0.01, ∗P<0.05).
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Figure 4: Changes of IL-6 in serum (n = 1 0 ) .T h el e v e lo fI L - 6w a s
measured by ELISA. Data are expressed as means ± SD (∗P<0.05).
angelica, Radix Rehmanniae, Pheretima, Radix Glycyrrhizae,
Rhizoma Drynariae, Polygoni Cuspidati, Caulis Spatholobi,
Bombyx Batryticatus, Herba Erodii, Herba Pyrolae, Allomy-
rinadichotoma,Scorpio,RadixRehmanniaePreparata,Eupol-
yphaga Seu Steleophaga, Scolopendra, Zaocys (stir-fried with
wine), Cynanchi Paniculati, Herba Aristolochiae, Rhizoma
Corydalis, Herba Epimedii, Nidus Vespae (stir-baking), and
Nidus Vespae. One study reported that YJB eﬀectively treated
arthritis in rats [11], and our results showing that YJB
aﬀects the balance of proinﬂammatory cytokines IL-6/IL-10
support its anti-CIA activity, further. IL-10 and IL-6 are
important in the development of RA [22]. The exogenous
addition of IL-10 in vivo has been shown to aﬀect the
immunopathological processes involved in RA, although the
outcome of clinical studies using IL-10 was disappointing
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Figure 5: Changes of IL-10 in serum (n = 10). The level of IL-10
was measured by ELISA. Data are expressed as means ± SD (∗∗P<
0.01, ∗P<0.05).
[23]. IL-6 is closely associated with the pathological process
of RA. The evidence suggests that, in contrast to IL-6, IL-10
plays an active role in ameliorating arthritis caused by de-
generation. In our study, YJB treatment increased IL-10 and
decreased IL-6 in the serum of arthritic rats with castration-
induced TCM kidney deﬁciency.
Anothermajorﬁndinginthisstudywastheidentiﬁcation
of 2 kinds of metabolites, including LPC and FFA, which are
directlyrelevanttolipidmetabolism.Accordingtopreviously
published data and biochemical databases (e.g., KEGG and
METLIN), we demonstrated that FFA and LPC are critical
intermediates of fatty acid metabolism [24]. As shown in
Figure 7, decreased LPC levels were observed in the serum
of YJB-treated rats. Researchers have demonstrated that LPC
is involved in inﬂammatory disease pathogenesis, and LPC
levels could increase in response to reactive oxygen species
(ROS) and inﬂammatory conditions, such as RA, lung
infection, diabetes, and liver injury [25–27]. The decreased
level of LPC in response to YJB treatment could disturb
choline and cholesterol metabolism, which might be the
pharmacological mechanism of the compound. Along with
decreased LPC, the increased level of FFA suggests increased
acetyl-CoA, an important substrate in the TCA cycle, which
is critical for energy production. The metabolic proﬁle
implies that YJB may inﬂuence lipid metabolism regulation
in CIA rats with castration-induced TCM kidney deﬁciency.
Androgens are involved in the pathogenesis of RA to a
surprising degree. Their modulation of the activity of cells
involvedintheimmuneinﬂammatoryresponseisdependent
on the androgen/estrogen ratio and concentration [28].
Clinical studies have revealed the eﬀects of androgens on
the treatment of autoimmune and chronic inﬂammatory
diseases, such as RA, SLE, and tumors [29]. Unfortunately,
conclusions from studies of sex hormone therapy were
often paradoxical [30, 31]. The biological signiﬁcance of6 Evidence-Based Complementary and Alternative Medicine
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Figure 7: The value of variable important parameters (VIPs) for (a) LPC and (b) FFA by groups ∗P<0.05 versus the castrated CIA group
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the association between androgens and RA remains unclear.
In this study, we limit the conclusion to the eﬀect of YJB,
which protected against castration-induced androgen deﬁ-
ciency in arthritic male rats by downregulating IL-6 (a pro-
inﬂammatory cytokine), upregulating IL-10 (an anti-in-
ﬂammatory cytokine), and regulating lipid metabolism.
Honestly, the major limitation of this study is that the
metabolomic data were not fully collected and analyzed.
Because lipid metabolism is a likely mechanism of YJB in the
treatment of CIA rats, a more thorough metabolomic study
is necessary.
5. Conclusion
In conclusion, castration-induced TCM kidney deﬁciency
signiﬁcantlyincreasedtheseverityofarthritisinrats.YJBhad
protective eﬀects on CIA rats with castration-induced TCM
kidney deﬁciency, and its pharmacological mechanism likely
involved lipid metabolites, including FFA and LPC. These
results suggest that YJP should be used for the treatment of
RA with TCM kidney deﬁciency pattern.
Acknowledgments
This study is supported in part by the projects from Ministry
of Sciences and Technology of China (No. 2009ZX09502-
019, 2006BAI08B01-01), National Science Foundation of
China (No. 30825047, 30902000, 30901941, 30701067 and
81001676).
References
[1] S. E. Sweeney and G. S. Firestein, “Rheumatoid arthritis:
regulation of synovial inﬂammation,” International Journal of
BiochemistryandCellBiology,vol.36,no.3,pp.372–378,2004.
[ 2 ]D .P .M .S y m m o n s ,E .M .B a r r e t t ,C .R .B a n k h e a d ,D .G .I .
Scott, and A. J. Silman, “The incidence of rheumatoid arthritis
in the United Kingdom: results from the Norfolk Arthritis
Register,” British Journal of Rheumatology,v o l .3 3 ,n o .8 ,p p .
735–739, 1994.
[ 3 ]T .D .S p e c t o r ,L .A .P e r r y ,G .T u b b ,A .J .S i l m a n ,a n dE .
C. Huskisson, “Low free testosterone levels in rheumatoid
arthritis,” Annals of the Rheumatic Diseases,v o l .4 7 ,n o .1 ,p p .
65–68, 1988.
[4] K. Forslind, I. Hafstr¨ o m ,M .A h l m´ en, and B. Svensson, “Sex: a
major predictor of remission in early rheumatoid arthritis?”
Annals of the Rheumatic Diseases, vol. 66, no. 1, pp. 46–52,
2007.
[5] Y. Wang, H. Y. Zhao, D. H. Ju et al., “Eﬀect of kidney
deﬁciencyontheoccurrenceanddevelopmentofBisyndrome
(rheumatoid arthritis),” Chinese Journal of Basic Medicine in
Traditional Chinese Medicine, vol. 15, no. 12, pp. 892–895,
2009 (Chinese).
[6] L. C. Zhu, “Discussion on the medicine experience from three
mainsymptomsofBisyndrome,”BeijingJournalofTraditional
Chinese Medicine, vol. 5, pp. 5–6, 1992 (Chinese).
[7] D. H. Zhou, Z. Q. Zhou, and W. H. Zhu, “Zhu Liangchun’s
experience prescription in 38 cases treatment of rheumatoid
arthritis,” Journal of New Chinese Medicine,v o l .3 9 ,n o .9 ,p p .
71–72, 2007 (Chinese).
[8] S. Li, X. Hu, and Z. Jing, “Therapeutic eﬀect of Yi Shen Juan
Bi pill on rheumatoid arthritis,” Zhejiang Clinical Medicine
Journal, vol. 10, pp. 628–629, 2008 (Chinese).
[9] P. K. Perera, Y. Li, C. Peng, W. Fang, and C. Han, “Im-
munomodulatory activity of a Chinese herbal drug Yi Shen
Juan Bi in adjuvant arthritis,” Indian Journal of Pharmacology,
vol. 42, no. 2, pp. 65–69, 2010.
[10] P. K. Perera, C. Peng, X. Lv, Y. M. Li, W. R. Fang, and C. F.
Han, “Eﬀects of Yishen Juanbi (YJB) pill on experimental
rheumatoid arthritis,” Chinese Journal of Natural Medicines,
vol. 8, no. 1, pp. 57–61, 2010.
[11] P. K. Perera, C. Peng, L. Xue, Y. Li, and C. Han, “Ex vivo and
in vivo eﬀect of Chinese herbal pill Yi Shen Juan Bi (YJB)
on experimental arthritis,” Journal of Ethnopharmacology, vol.
134, no. 1, pp. 171–175, 2011.
[12] T. Zhou, “Study of Yishen Juanbi Pill combined with
methotrexate on elderly onset rheumatoid arthritis,” Journal
of Clinical Rational Drug Use, vol. 2, no. 8, pp. 13–15, 2009
(Chinese).
[13] J. L. Ai, A. P. Lu, S. J. Xu et al., “Experimental study on
mechanismofgonadaldysfunctionofBisyndromewthkidney
deﬁciency,” Chinese Journal of Basic Medicine in Traditional
Chinese Medicine, vol. 1, no. 1, pp. 42–44, 1995 (Chinese).
[14] A. K. Kuang, J. L. Chen, Y. R. Lu et al., “Changes of sex
hormone in female type II diabetics, coronary heart disease,
essential hypertension and its relations with kidney deﬁ-
ciency,”JournalofIntegratedTraditionalandWesternMedicine,
vol. 9, no. 6, pp. 331–334, 1989 (Chinese).
[15] S. Xu, A. P. Lu, A. M. Wang et al., “Eﬀect of kidney deﬁciency
caused by ovariectomy on serum osteocalcium level and
tumor necrosis factor in mice with collagen induced arthritis,”
ChineseJournalofIntegratedTraditionalandWesternMedicine,
vol. 19, no. 1, pp. 34–36, 1999 (Chinese).
[16] J. K. Nicholson, “Global systems biology, personalized med-
icine and molecular epidemiology,” Molecular Systems Biology,
vol. 2, article 52, 2006.
[17] J. Li, Y. Lu, C. Xiao et al., “Comparison of toxic reaction of
Tripterygium wilfordii multiglycoside in normal and adjuvant
arthritic rats,” Journal of Ethnopharmacology, vol. 135, no. 2,
pp. 270–277, 2011.
[18] M. Hegen, J. C. Keith, M. Collins, and C. L. Nickerson-
Nutter,“Utilityofanimalmodelsforidentiﬁcationofpotential
therapeuticsforrheumatoidarthritis,”AnnalsoftheRheumatic
Diseases, vol. 67, no. 11, pp. 1505–1515, 2008.
[ 1 9 ]Y .G .C h o ,M .L .C h o ,S .Y .M i n ,a n dH .Y .K i m ,“ T y p eI I
collagen autoimmunity in a mouse model of human rheuma-
toid arthritis,” Autoimmunity Reviews, vol. 7, no. 1, pp. 65–70,
2007.
[20] P. Larsson, S. Kleinau, R. Holmdahl, and L. Klareskog, “Hom-
ologous type II collagen-induced arthritis in rats. Characteri-
zation of the disease and demonstration of clinically distinct
forms of arthritis in two strains of rats after immunization
with the same collagen preparation,” Arthritis and Rheuma-
tism, vol. 33, no. 5, pp. 693–701, 1990.
[21] K. Imada, N. Lin, C. Liu et al., “Nobiletin, a citrus poly-
methoxy ﬂavonoid, suppresses gene expression and produc-
tion of aggrecanases-1 and -2 in collagen-induced arthritic
mice,” Biochemical and Biophysical Research Communications,
vol. 373, no. 2, pp. 181–185, 2008.
[22] M. Feldmann, F. M. Brennan, and R. N. Maini, “Role of
cytokines in rheumatoid arthritis,” Annual Review of Im-
munology, vol. 14, pp. 397–440, 1996.8 Evidence-Based Complementary and Alternative Medicine
[23] J. A. G. Van Roon, S. Wijngaarden, F. P. J. G. Lafeber, C.
Damen, J. G. J. Van De Winkel, and J. W. J. Bijlsma, “Inter-
leukin 10 treatment of patients with rheumatoid arthritis
enhances Fcγ receptor expression on monocytes and re-
sponsiveness to immune complex stimulation,” Journal of
Rheumatology, vol. 30, no. 4, pp. 648–651, 2003.
[24] R. Stroh, T. A. Christopher, B. L. Lopez, Y. P. Guo, M. Amico-
Roxas, and X. L. Ma, “L-propionyl carnitine, an endogenous
ester in fatty acid metabolism, exerts anti-shock and endothe-
lial protective eﬀects in rat splanchnic ischemia-reperfusion
injury,” Shock, vol. 9, no. 3, pp. 216–222, 1998.
[25] T. Matsumoto, T. Kobayashi, and K. Kamata, “Role of
lysophosphatidylcholine (LPC) in atherosclerosis,” Current
Medicinal Chemistry, vol. 14, no. 30, pp. 3209–3220, 2007.
[26] C. Schober, J. Schiller, F. Pinker, J. G. Hengstler, and B. Fuchs,
“Lysophosphatidylethanolamine is—in contrast to—choline
10.1016/j.bioorg.2009.09.002generated under in vivo condi-
tionsexclusivelybyphospholipaseA2 butnotbyhypochlorous
acid,” Bioorganic Chemistry, vol. 37, no. 6, pp. 202–210, 2009.
[27] B. Fuchs, J. Schiller, U. Wagner, H. H¨ antzschel, and K. Arnold,
“The phosphatidylcholine/lysophosphatidylcholine ratio in
human plasma is an indicator of the severity of rheumatoid
arthritis: investigations by 31P NMR and MALDI-TOF MS,”
Clinical Biochemistry, vol. 38, no. 10, pp. 925–933, 2005.
[28] C. C. G. Chen and C. R. Parker, “Adrenal androgens and the
immune system,” Seminars in Reproductive Medicine, vol. 22,
no. 4, pp. 369–377, 2004.
[29] M. Cutolo, B. Seriolo, B. Villaggio, C. Pizzorni, C. Craviotto,
and A. Sulli, “Androgens and estrogens modulate the immune
and inﬂammatory responses in rheumatoid arthritis,” Annals
of the New York Academy of Sciences, vol. 966, pp. 131–142,
2002.
[30] E.W.Karlson,L.B.Chibnik,M.McGrathetal.,“Aprospective
study of androgen levels, hormone-related genes and risk of
rheumatoid arthritis,” Arthritis Research and Therapy, vol. 11,
no. 3, article R97, 2009.
[31] M. Cutolo, “Androgens in rheumatoid arthritis: when are they
eﬀectors?” Arthritis Research & Therapy, vol. 11, no. 5, p. 126,
2009.